Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

  1. Alcaraz, A.
  2. González-López, R.
  3. Morote, J.
  4. De La Piedra, C.
  5. Meseguer, C.
  6. Esteban, E.
  7. Climent, M.
  8. González-Gragera, B.
  9. Álvarez-Ossorio, J.-L.
  10. Chirivella, I.
  11. Mellado, B.
  12. Lara, P.-C.
  13. Vázquez, F.
  14. Contreras, J.-A.
  15. Carles, J.
  16. Murias, A.
  17. Calderero, V.
  18. Comet-Batlle, J.
  19. González-Del Alba, A.
  20. León-Mateos, L.
  21. Mañas, A.
  22. Segarra, J.
  23. Lassa, A.
  24. González-Enguita, C.
  25. Méndez, M.-J.
  26. Samper, P.
  27. Unda, M.
  28. Mahillo-Fernández, I.
  29. Bellmunt, J.
  30. Show all authors +
Journal:
British Journal of Cancer

ISSN: 0007-0920,  1532-1827

Year of publication: 2013

Volume: 109

Issue: 1

Pages: 121-130

Type: Article

DOI: 10.1038/BJC.2013.272 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus